Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMPLIFY-HF: Withdrawal of MRAs in Stable Heart Failure With Improved LVEF
NCT07489547Phase 3Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Mar 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of canrenoic acid in heart failure (HF), sponsored by Hospital de Clínicas de Porto Alegre. Started Mar 2025; status: recruiting.
02
Drugs
canrenoic acid
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07489547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07489547.